|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute of Mental Health (NIMH) |
| Information provided by: | National Institute of Mental Health (NIMH) |
| ClinicalTrials.gov Identifier: | NCT00247637 |
Purpose
This is a study of the genetic basis of brain dysfunction in people with schizophrenia.
| Condition |
|
Schizophrenia |
| MedlinePlus related topics: | Mental Health Schizophrenia |
| Study Type: | Observational |
| Study Design: | Prospective |
| Official Title: | The Genetics of Endophenotypes and Schizophrenia |
| Estimated Enrollment: | 1680 |
| Study Start Date: | May 2003 |
| Estimated Study Completion Date: | May 2008 |
Schizophrenia is a disabling disorder that is associated with specific inheritable neurobiologic deficits. These deficits can cause problems with memory, visual attention, information processing, and other aspects of daily living. Understanding the genetic components of these deficits in people with schizophrenia and their unaffected family members may help uncover the neurobiological basis, risk factors, and heritability of the disease. In addition, the information may serve to create more effective treatments and possibly a cure for the disease. This study will serve to provide information about the genetic basis of known inherited neurobiological deficits in people with schizophrenia. In turn, this may guide further studies on the genetics of schizophrenia.
Participants will attend 2 study visits, each of which will last approximately 4 hours. The first will include blood tests and diagnostic interviews of participating families to evaluate the presence of schizophrenic symptoms. The second study visit will entail four neurocognitive and neurophysiological tests. Participants will first have a pre-pulse inhibition test, which uses electrodes to measure eye blinking. Electrodes will also be placed on participants' head, ears, and around their eyes to measure brain waves. Next, participants will undergo an oculomotor test, during which they will wear glasses fitted with sensors that record eye movement. Participants will then be asked to repeat a list of words, letters, and numbers read by a researcher. Last, participants will undergo a computerized performance test requiring them to watch the computer screen and click a mouse whenever they see a number between 0 and 9. Each study visit will take approximately 4 hours.
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria for Participating Families:
Exclusion Criteria:
Contacts and Locations| Contact: Andras A. Kovach, BS | 866-359-2496 | akovach@ucsd.edu |
| United States, California | |||||
| University of California, San Diego | Recruiting | ||||
| San Diego, California, United States, 92103 | |||||
| Contact: Barbara Haugeland, PhD 619-543-7201 bhaugeland@ucsd.edu | |||||
| Principal Investigator: David Braff, MD | |||||
| University of California Los Angeles | Recruiting | ||||
| Los Angeles, California, United States, 90073 | |||||
| Contact: Karen Cornelius, PsyD 310-478-3711 ext 43929 karen.cornelius@med.va.gov | |||||
| Principal Investigator: Michael Green, PhD | |||||
| United States, Colorado | |||||
| University of Colorado Health Sciences Center | Recruiting | ||||
| Denver, Colorado, United States, 80220 | |||||
| Contact: Chris Cason, BS 303-807-7382 chris.cason@uchsc.edu | |||||
| Principal Investigator: Ann Olincy, MD | |||||
| United States, Massachusetts | |||||
| Harvard University | Recruiting | ||||
| Boston, Massachusetts, United States, 02115 | |||||
| Contact: Monica Landi, MSW 617-998-5015 cogs@bidmc.harvard.edu | |||||
| Principal Investigator: Larry Seidman, PhD | |||||
| United States, New York | |||||
| Mount Sinai School of Medicine | Recruiting | ||||
| New York, New York, United States, 10029 | |||||
| Contact: Robert Fieo, MA 212-659-5625 robert.fieo@mssm.edu | |||||
| Principal Investigator: Larry Siever, MD | |||||
| United States, Pennsylvania | |||||
| University of Pennsylvania | Recruiting | ||||
| Philadelphia, Pennsylvania, United States, 19104 | |||||
| Contact: Raquel E. Gur, MD, PhD 888-635-7780 cogs@bbl.med.upenn.edu | |||||
| Contact: Caryn Hussar 888-635-7780 cogs@bbl.med.upenn.edu | |||||
| Principal Investigator: Raquel E. Gur, MD, PhD | |||||
| United States, Washington | |||||
| University of Washington and VA Puget Sound Health Care System | Recruiting | ||||
| Seattle, Washington, United States, 98108 | |||||
| Contact: Denise Pritzl, LCSW 800-597-5441 seacogs@u.washington.edu | |||||
| Principal Investigator: Debby Tsuang, MD, MPH | |||||
| Study Director: | David Braff, MD | University of California, San Diego |
More Information
Click here for more information on the Schizophrenia Research Program 
  |
| Study ID Numbers: | R01 MH65571, R01 MH65707, R01 MH65578, R01 MH65588, R01 MH65554, R01 MH65562, DNBBS 7G-GRR |
| First Received: | October 31, 2005 |
| Last Updated: | May 19, 2008 |
| ClinicalTrials.gov Identifier: | NCT00247637 |
| Health Authority: | United States: Federal Government |
|
|